APA (7th ed.) Citation
(2026). Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells. PLOS ONE.
Chicago Style (17th ed.) Citation
"Combining Lenalidomide with IL-2 Family of Cytokines Enhances Activating Receptor and Perforin/granzyme Expression in NK Cells." PLOS ONE 2026.
MLA (9th ed.) Citation
"Combining Lenalidomide with IL-2 Family of Cytokines Enhances Activating Receptor and Perforin/granzyme Expression in NK Cells." PLOS ONE, 2026.
Warning: These citations may not always be 100% accurate.